Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
0.4548
-0.0152 (-3.23%)
Oct 14, 2026, 3:37 PM EDT - Market open
Caribou Biosciences Revenue
Caribou Biosciences had revenue of $1.50M in the quarter ending June 30, 2026, a decrease of -43.79%. This brings the company's revenue in the last twelve months to $10.04M, up 10.02% year-over-year. In the year 2025, Caribou Biosciences had annual revenue of $11.16M with 11.66% growth. That makes Caribou Biosciences the 37,309th largest company in the world by revenue and 4,896th in the United States.
Revenue (ttm)
$10.04M
Revenue Growth
+10.02%
P/S Ratio
5.02
Revenue / Employee
$103,454
Employees
97
Market Cap
48.76M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.16M | 1.17M | 11.66% |
| Dec 31, 2024 | 9.99M | -24.48M | -71.01% |
| Dec 31, 2023 | 34.48M | 20.63M | 148.91% |
| Dec 31, 2022 | 13.85M | 4.25M | 44.31% |
| Dec 31, 2021 | 9.60M | -2.76M | -22.35% |
| Dec 31, 2020 | 12.36M | 6.57M | 113.56% |
| Dec 31, 2019 | 5.79M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Hyperion DeFi | 1.40M |
| ImageneBio | 800.00K |
| Mereo BioPharma Group | 500.00K |
| Clene | 197.00K |
| Serina Therapeutics | 130.00K |
CRBU News
- 6 days ago - Caribou Biosciences moved to No Rating at BofA - TheFly
- 6 days ago - Caribou Biosciences downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 7 days ago - Why is Caribou Biosciences Stock (CRBU) Down 43% Today? - TipRanks
- 7 days ago - Caribou Biosciences downgraded to Market Perform from Outperform at Leerink - TheFly
- 7 days ago - Caribou Biosciences downgraded to Sector Perform from Outperform at RBC Capital - TheFly
- 7 days ago - Caribou Biosciences downgraded to Hold from Buy at Brookline - TheFly
- 7 days ago - Caribou Biosciences trading resumes - TheFly
- 7 days ago - Caribou to discontinue development activities, explore alternatives - TheFly